Supporters

The Advanced Prostate Summit titled "Advances in Prostate Cancer Screening & Management" is supported by educational grants from Bayer Healthcare Pharmaceuticals, Inc., Abbvie Inc., Millennium: The Takeda Oncology Company and Janssen Biotech, Inc.

CSL Behring
Bayer Healthcare Pharmaceuticals: One of the world's leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the United States, Bayer HealthCare Pharmaceuticals is comprised of the following business units: Women's Healthcare, Diagnostic Imaging, General Medicine, Hematology/Neurology and Oncology.
Abbvie Inc. a global biopharmaceutical company that has the ability to discover and advance innovative therapies and meet the health needs of people and societies around the globe.
Millennium: The Takeda Oncology Company combines the innovative science of a leading American biopharmaceutical company with the global assets – both intellectual and fiscal – of Japan's largest pharmaceutical company.
Janssen Biotech, Inc., a pharmaceutical company of Johnson & Johnson, provides medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health.

The Hemophilia Management Virtual Summit is supported by independent educational grants from CSL Behring LLC, Baxter Healthcare, and Grifols.

CSL Behring
CSL Behring is a global leader in the plasma protein biotherapeutics industry. We research, develop, manufacture and market biotherapies that are used to treat serious and rare conditions. Users of our therapies rely on them for their quality of life and, in many cases, for life itself.
Baxter
Baxter: A leader in healthcare for more than 80 years. Baxter assists healthcare professionals and their patients with treatment of complex medical conditions, including hemophilia to proactively shape the future of hemophilia treatment by focusing on personalized innovations and solutions.
Grifols is a global healthcare company whose mission is to improve the health and well being of people around the world. We accomplish this mission by producing life-saving protein therapies for patients and by providing hospitals, pharmacies and healthcare professionals with the tools they need to deliver expert medical care.

The Hematologic Malignancies Virtual Summit is supported by independent educational grants from Millennium: The Takeda Oncology Company and Genentech, USA.

Millennium
Millennium: The Takeda Oncology Company combines the innovative science of a leading American biopharmaceutical company with the global assets – both intellectual and fiscal – of Japan's largest pharmaceutical company.
Genentech uses human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, we are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.

The Men's Health Virtual Summit titled "Managing the Patient with BPH-LUTS and Erectile Dysfunction" is supported by an educational grant from Lilly.

Lilly focuses on speeding innovation and improving outcomes for individual patients, and boasts one of the largest clinical pipelines in the oncology industry.

The Breakthrough Cancer Pain Summit titled "Improving the Recognition and Management of Breakthrough Cancer Pain" is supported by an educational grant from Teva Pharmaceuticals.

Teva: As the largest generic pharmaceutical company in the country, Teva Pharmaceuticals understands the importance of making safe, quality medications accessible—and affordable.

The Colorectal Cancer Virtual Summit titled "Moving Toward a Personalized Approach to Screening and Management" is supported by an educational grant from Ferring Pharmaceuticals, Inc. and Lilly.

Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of infertility, obstetrics, urology, gastroenterology, endocrinology and osteoarthritis.
Lilly focuses on speeding innovation and improving outcomes for individual patients, and boasts one of the largest clinical pipelines in the oncology industry.

For information on becoming a partner email us at Info@OMedLive.com

Forgot Password Click Here to Register